Literature DB >> 29309223

Medicare Advantage Ratings And Voluntary Disenrollment Among Patients With End-Stage Renal Disease.

Qijuan Li1, Amal N Trivedi2, Omar Galarraga3, Michael E Chernew4, Daniel E Weiner5, Vincent Mor6.   

Abstract

Populations with intensive health care needs and high care costs may be attracted to insurance plans that have high quality ratings, but patients may be likely to disenroll from a plan if their care needs are not met. We assessed the association between publicly reported Medicare Advantage plan star ratings and voluntary disenrollment of incident dialysis patients in the following year over the period 2007-13. We found that Medicare Advantage (MA) plans with lower star ratings had significantly higher rates of disenrollment by incident dialysis patients in the following year. Compared to MA plans with 4.0 or more stars, adjusted disenrollment rates were 3.9 percentage points higher for plans with 3.5 stars, 5.0 percentage points higher for those with 3.0 stars, and 12.1 percentage points higher for those with 2.5 or fewer stars. These findings suggest that low plan quality may lead to increased expenditures, as this high-cost population generally must shift from Medicare Advantage to traditional Medicare upon disenrollment.

Entities:  

Keywords:  Medicare Advantage plan star rating; end stage renal disease; voluntary disenrollment

Mesh:

Year:  2018        PMID: 29309223      PMCID: PMC6021124          DOI: 10.1377/hlthaff.2017.0974

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  19 in total

1.  Do consumers respond to publicly reported quality information? Evidence from nursing homes.

Authors:  Rachel M Werner; Edward C Norton; R Tamara Konetzka; Daniel Polsky
Journal:  J Health Econ       Date:  2012-01-10       Impact factor: 3.883

Review 2.  Quality and consumer decision making in the market for health insurance and health care services.

Authors:  Jonathan T Kolstad; Michael E Chernew
Journal:  Med Care Res Rev       Date:  2008-11-24       Impact factor: 3.929

3.  High-Cost Patients Had Substantial Rates Of Leaving Medicare Advantage And Joining Traditional Medicare.

Authors:  Momotazur Rahman; Laura Keohane; Amal N Trivedi; Vincent Mor
Journal:  Health Aff (Millwood)       Date:  2015-10       Impact factor: 6.301

Review 4.  US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Authors:  Rajiv Saran; Bruce Robinson; Kevin C Abbott; Lawrence Y C Agodoa; Patrick Albertus; John Ayanian; Rajesh Balkrishnan; Jennifer Bragg-Gresham; Jie Cao; Joline L T Chen; Elizabeth Cope; Sai Dharmarajan; Xue Dietrich; Ashley Eckard; Paul W Eggers; Charles Gaber; Daniel Gillen; Debbie Gipson; Haoyu Gu; Susan M Hailpern; Yoshio N Hall; Yun Han; Kevin He; Paul Hebert; Margaret Helmuth; William Herman; Michael Heung; David Hutton; Steven J Jacobsen; Nan Ji; Yan Jin; Kamyar Kalantar-Zadeh; Alissa Kapke; Ronit Katz; Csaba P Kovesdy; Vivian Kurtz; Danielle Lavalee; Yi Li; Yee Lu; Keith McCullough; Miklos Z Molnar; Maria Montez-Rath; Hal Morgenstern; Qiao Mu; Purna Mukhopadhyay; Brahmajee Nallamothu; Danh V Nguyen; Keith C Norris; Ann M O'Hare; Yoshitsugu Obi; Jeffrey Pearson; Ronald Pisoni; Brett Plattner; Friedrich K Port; Praveen Potukuchi; Panduranga Rao; Kaitlyn Ratkowiak; Vanessa Ravel; Debabrata Ray; Connie M Rhee; Douglas E Schaubel; David T Selewski; Sally Shaw; Jiaxiao Shi; Monica Shieu; John J Sim; Peter Song; Melissa Soohoo; Diane Steffick; Elani Streja; Manjula Kurella Tamura; Francesca Tentori; Anca Tilea; Lan Tong; Megan Turf; Dongyu Wang; Mia Wang; Kenneth Woodside; April Wyncott; Xin Xin; Wei Zang; Lindsay Zepel; Sai Zhang; Hui Zho; Richard A Hirth; Vahakn Shahinian
Journal:  Am J Kidney Dis       Date:  2017-03       Impact factor: 8.860

5.  Form CMS-2728 data versus erythropoietin claims data: implications for quality of care studies.

Authors:  Anne C Beaubrun; Eiichiro Kanda; T Christopher Bond; William M McClellan
Journal:  Ren Fail       Date:  2012-12-11       Impact factor: 2.606

6.  New risk-adjustment system was associated with reduced favorable selection in medicare advantage.

Authors:  J Michael McWilliams; John Hsu; Joseph P Newhouse
Journal:  Health Aff (Millwood)       Date:  2012-12       Impact factor: 6.301

7.  Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosis.

Authors:  Elena B Elkin; Nicole Ishill; Gerald F Riley; Peter B Bach; Mithat Gonen; Colin B Begg; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2008-07-08       Impact factor: 13.506

8.  Risk-adjustment system for the Medicare capitated ESRD program.

Authors:  Jesse M Levy; John Robst; Melvin J Ingber
Journal:  Health Care Financ Rev       Date:  2006

9.  Acceptance of selective contracting: the role of trust in the health insurer.

Authors:  Romy E Bes; Sonja Wendel; Emile C Curfs; Peter P Groenewegen; Judith D de Jong
Journal:  BMC Health Serv Res       Date:  2013-10-02       Impact factor: 2.655

10.  Beneficiary reported experience and voluntary disenrollment in Medicare managed care.

Authors:  Terry R Lied; Steven H Sheingold; Bruce E Landon; James A Shaul; Paul D Cleary
Journal:  Health Care Financ Rev       Date:  2003
View more
  13 in total

1.  Higher Medicare Advantage Star Ratings Are Associated With Improvements In Patient Outcomes.

Authors:  David J Meyers; Amal N Trivedi; Ira B Wilson; Vincent Mor; Momotazur Rahman
Journal:  Health Aff (Millwood)       Date:  2021-02       Impact factor: 6.301

2.  Switching Between Medicare Advantage And Traditional Medicare Before And After The Onset Of Functional Disability.

Authors:  Claire K Ankuda; Katherine A Ornstein; Kenneth E Covinsky; Evan Bollens-Lund; Diane E Meier; Amy S Kelley
Journal:  Health Aff (Millwood)       Date:  2020-05       Impact factor: 6.301

3.  Turnover among new Medicare Advantage enrollees may be greater than perceived.

Authors:  Jeffrey Dong; Alan M Zaslavsky; John Z Ayanian; Bruce E Landon
Journal:  Am J Manag Care       Date:  2022-10       Impact factor: 3.247

4.  Limited Medigap Consumer Protections Are Associated With Higher Reenrollment In Medicare Advantage Plans.

Authors:  David J Meyers; Amal N Trivedi; Vincent Mor
Journal:  Health Aff (Millwood)       Date:  2019-05       Impact factor: 6.301

5.  Health Care Utilization, Care Satisfaction, and Health Status for Medicare Advantage and Traditional Medicare Beneficiaries With and Without Alzheimer Disease and Related Dementias.

Authors:  Sungchul Park; Lindsay White; Paul Fishman; Eric B Larson; Norma B Coe
Journal:  JAMA Netw Open       Date:  2020-03-02

6.  Trends in Peritoneal Dialysis Use in the United States after Medicare Payment Reform.

Authors:  Caroline E Sloan; Cynthia J Coffman; Linda L Sanders; Matthew L Maciejewski; Shoou-Yih D Lee; Richard A Hirth; Virginia Wang
Journal:  Clin J Am Soc Nephrol       Date:  2019-11-21       Impact factor: 8.237

7.  The Relationship Between Medicare Advantage Star Ratings and Enrollee Experience.

Authors:  David J Meyers; Momotazur Rahman; Ira B Wilson; Vincent Mor; Amal N Trivedi
Journal:  J Gen Intern Med       Date:  2021-04-12       Impact factor: 5.128

8.  Opening the black box: Evaluating the care of people with serious illness in Medicare Advantage.

Authors:  Claire K Ankuda; Lauren J Hunt
Journal:  J Am Geriatr Soc       Date:  2021-06-30       Impact factor: 5.562

9.  Preferred Provider Relationships Between Medicare Advantage Plans and Skilled Nursing Facilities Reduce Switching Out of Plans: An Observational Analysis.

Authors:  Elizabeth M Goldberg; Laura M Keohane; Vincent Mor; Amal N Trivedi; Hye-Young Jung; Momotazur Rahman
Journal:  Inquiry       Date:  2018 Jan-Dec       Impact factor: 1.730

10.  Incentivizing Excellent Care to At-Risk Groups with a Health Equity Summary Score.

Authors:  Denis Agniel; Steven C Martino; Q Burkhart; Katrin Hambarsoomian; Nate Orr; Megan K Beckett; Cara James; Sarah Hudson Scholle; Shondelle Wilson-Frederick; Judy Ng; Marc N Elliott
Journal:  J Gen Intern Med       Date:  2019-11-11       Impact factor: 6.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.